# Kryptos Biotechnologies, Inc.

> Kryptos Biotechnologies is a Hayward, California life-sciences startup that reinvented the PCR machine around light. Its proprietary photothermal heating uses an optical thin film to convert light into precisely controlled heat, driving an Ultrafast Photonic PCR engine that runs 40 thermal-cycles in under 10 minutes. That engine powers Kuick, a sample-to-answer molecular diagnostics system that delivers lab-grade infectious-disease results at the point of care in roughly 20 minutes. Founded in 2017 and backed by a $10M Series A led by Osang Healthcare, Kryptos is pushing toward U.S. clinical trials and FDA clearance.

- **Founded:** 2017
- **Headquarters:** Hayward, California, United States
- **Founders:** Jun Ho Son (Co-Founder & CEO), Jinyong Lee (Co-Founder)
- **Team size:** ~7 employees
- **Products:** Kuick, Ultrafast Photonic PCR, Photothermal Heating Platform
- **Notable:** Developed Ultrafast Photonic PCR completing 40 thermal cycles in under 10 minutes at conventional-PCR sensitivity., Built Kuick, a sample-to-answer point-of-care system delivering results in ~20 minutes., Raised $10M Series A led by Osang Healthcare (March 2024).

## Products & services

- **Kuick** — A rapid, easy-to-use, affordable sample-to-answer molecular diagnostic system for point-of-care testing. It combines Ultrafast Photonic PCR with solid-phase extraction sample prep in a low-cost disposable cartridge, delivering results in about 20 minutes.
- **Ultrafast Photonic PCR** — A PCR thermal-cycling engine built on photothermal heating that completes 40 cycles in under 10 minutes while maintaining conventional PCR sensitivity.
- **Photothermal Heating Platform** — The core technology: an optical thin film that converts light into precisely controlled, non-contact, localized heat, enabling miniaturized molecular diagnostic devices.

## Achievements

- Developed Ultrafast Photonic PCR completing 40 thermal cycles in under 10 minutes at conventional-PCR sensitivity.
- Built Kuick, a sample-to-answer point-of-care system delivering results in ~20 minutes.
- Raised $10M Series A led by Osang Healthcare (March 2024).
- Awarded a $1.2M RIGHT Foundation grant (April 2025) for a multiplex STI test.
- Exhibited at major clinical-lab conferences including AACC/ADLM.
- Total funding of roughly $21.6M since 2017.

## Latest updates

- **2025-04** — RIGHT Foundation awarded Kryptos $1.2M to develop a 30-minute multiplex STI test with Osang Healthcare.
- **2025** — Osang Healthcare added roughly $2M in follow-on investment as the photonic PCR system nears its FDA path; U.S. clinical trials targeted for 2025.
- **2024-03** — Closed a $10M Series A round led by Osang Healthcare to fund clinical studies and FDA approval.

## Links

- Website: https://kryptosbio.com
- LinkedIn: https://www.linkedin.com/company/kryptosbio

---

Profile page: https://yespress.io/kryptos-biotechnologies-inc
Published by YesPress — https://yespress.io
Last updated: 2026-07-11